Form 4: Guardant Health CFO Michael Bell Awarded Stock Options and Restricted Stock Units

Guardant Health's Chief Financial Officer, Michael Bell, received stock options and restricted stock units on November 8, 2024, as part of his compensation.

Summary

• Michael Bell, the Chief Financial Officer of Guardant Health, was granted stock options for 59,534 shares and 39,689 restricted stock units on November 8, 2024.
• The stock options have an exercise price of $28.61 per share and vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting monthly over the following two years.
• The restricted stock units also vest over a three-year period, with 33% vesting on October 1, 2025, and the remaining 67% vesting quarterly over the following two years.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The granting of stock options and restricted stock units aligns the CFO's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CFO.

Industry Context

This type of equity-based compensation is common for executives in publicly traded companies, particularly in the biotech and healthcare sectors, to incentivize performance and retention.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard practice for executive compensation in the biotechnology industry.
• Companies like Exact Sciences and Illumina also use similar equity-based compensation packages for their executives.
• The vesting schedule of three years with a cliff at one year followed by monthly or quarterly vesting is also a common structure.

Stakeholder Impact

• Shareholders may view this as a positive sign of management alignment.
• Employees may see this as a standard practice for executive compensation.

Key Dates

Keywords

stock options, restricted stock units, executive compensation, insider trading, Guardant Health, Michael Bell, vesting